Solutions
eClinical
TrialMaster
CTMS Master
RTSM Master
AnjuEPS
Medical Affairs
IRMS MAX
iCare MAX
Pubstrat MAX
MA Knowledge
Data Science
TA Scan
Services
eClinical Services
Medical Affairs Services
Data Science Services
Technology
Resources
Insights
Press Releases
Events
Partner Program
Company
About Anju
Careers
Management
Contact Us
Contact Support
Request A Demo
Inquiries & Locations
Home
/
Archives for Lisa Pahl
/
Page 3
Author:
Lisa Pahl
Tags
Data Analysis on Latest Clinical Research for Parkinson’s Day
Anju Appoints Laurence Birch as Chief Executive Officer
SCOPE Europe 2022: Don’t Miss These Events
Understanding the Value of Blockchain for Clinical Trial Data
Benefits and Challenges in Virtual Clinical Trials
Clinical Trial Data Privacy: What Trial Managers Need to Know
Joe Alea Appointed EVP of Product Development at Anju
Working With Disparate Data Sources To Improve Your Trials
Future of Decentralized Trials: Anju EVP’s Predictions
Can’t Miss Sessions at ACDM22
How Historical Data and Controls Improve Clinical Trials
Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
Impact of Cybersecurity and Data Privacy on Medical Affairs Teams
6th European Clinical Research Conference: Presentations
Overcoming Accessibility Challenges in International Clinical Trials
How AI and Machine Learning Are Reshaping Clinical Trials
Gustave Roussy Renews TrialMaster EDC Agreement with Anju
Managing Multiple Sources within the Clinical Data Ecosystem
The Post-Pandemic Future of Medical Information Call Centers
Enhancing Trial Planning with Screening and Randomization
How To Empower Medical Science Liaisons With Data, and Why You Should
Steve Rosenberg Joins Anju’s Board of Directors
What Challenges Face Researchers With Direct-To-Patient Trials
Choosing a Medical Affairs CRM Platform: Key Considerations
Page navigation
‹
Page
1
Page
2
Current Page
3
Page
4
Page
5
›
»
Data Protection
|
Privacy Policy
|
Sitemap
©2023 All rights reserved
To top
